Table 2 Major CRS + HIPEC characteristics of PMP patients between STS and LTS groups
From: Long-term survival in patients with PMP: a single-institutional retrospective study from China
Variable | STS group (n = 162) | LTS group (n = 39) | p-value |
|---|---|---|---|
Operative duration (min), median (range) | 620 (24–990) | 600 (120–1080) | 0.538 |
Resected organs, median (range) | 0.252 | ||
< 3 | 79 (48.8) | 23 (59.0) | |
≥ 3 | 83 (51.2) | 16 (41.0) | |
Anastomosis, n (%) | 0.624 | ||
0 | 56 (34.6) | 17 (43.6) | |
1 | 66 (40.7) | 14 (35.9) | |
≥ 2 | 37 (22.8) | 8 (20.5) | |
NA | 3 (1.9) | 0 (0.0) | |
PCI, n (%) | 0.020 | ||
< 20 | 18 (11.1) | 10 (25.6) | |
≥ 20 | 143 (88.3) | 29 (74.4) | |
NA | 1 (0.6) | 0 (0.0) | |
CC, n (%) | 0.006 | ||
0–1 | 42 (25.9) | 19 (48.7) | |
2–3 | 118 (72.8) | 20 (51.3) | |
NA | 2 (1.2) | 0 (0.0) | |
Stripped peritoneum area, median (range) | 5 (0–9) | 4 (0–9) | 0.446 |
Blood loss volume (mL), median (range) | 600 (50–5000) | 500 (200–3500) | 0.278 |
Fluid transfusion volume (mL), median (range) | 6810 (1000–102,500) | 6200 (2000–12,900) | 0.074 |
Urine volume (mL), median (range) | 1600 (400–5000) | 1500 (600–5000) | 0.694 |
RBC transfusion volume (U), median (range) | 4 (0–20) | 3 (0–16) | 0.563 |
Plasma transfusion volume (mL), median (range) | 800 (0–2000) | 600 (0–1600) | 0.797 |
Ascites volume (mL), median (range) | 1300 (0–20,000) | 1200 (0–10,000) | 0.766 |
HIPEC regiment | 0.776 | ||
120-mg cisplatin + docetaxel 120 mg | 134 (82.7) | 33 (84.6) | |
120-mg cisplatin + mitomycin 30 mg | 28 (17.3) | 6 (15.4) |